Venture Life Group (LON:VLG) Shares Pass Above 50 Day Moving Average – Should You Sell?

Venture Life Group plc (LON:VLG)’s stock price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 63.14 and traded as high as GBX 69.80. Venture Life Group shares last traded at GBX 69.49, with a volume of 189,623 shares trading hands.

Venture Life Group Price Performance

The company has a current ratio of 4.71, a quick ratio of 1.48 and a debt-to-equity ratio of 0.82. The business has a 50-day moving average price of GBX 63.14 and a two-hundred day moving average price of GBX 65.19. The firm has a market capitalization of £84.30 million, a price-to-earnings ratio of 15.90, a PEG ratio of 5.67 and a beta of 0.22.

Insiders Place Their Bets

In related news, insider Paul McGreevy bought 93,887 shares of the company’s stock in a transaction on Tuesday, June 30th. The shares were purchased at an average cost of GBX 64 per share, with a total value of £60,087.68. Insiders acquired 174,094 shares of company stock valued at $11,012,928 over the last quarter. 7.45% of the stock is owned by company insiders.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.